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Abstract The present study describes the isolation and phar-
macological characterisation of the neurotoxin N-missulenatox-
in-Mb1a (N-MSTX-Mb1a) from the venom of the male Austra-
lian eastern mouse spider, Missulena bradleyi. This toxin was
isolated using reverse-phase high-performance liquid chromatog-
raphy and was subsequently shown to cause an increase in rest-
ing tension, muscle fasciculation and a decrease in indirect
twitch tension in a chick biventer cervicis nerve-muscle bioassay.
Interestingly, these e¡ects were neutralised by antivenom raised
against the venom of the Sydney funnel-web spider Atrax ro-
bustus. Subsequent whole-cell patch-clamp electrophysiology on
rat dorsal root ganglion neurones revealed that N-MSTX-Mb1a
caused a reduction in peak tetrodotoxin (TTX)-sensitive sodium
current, a slowing of sodium current inactivation and a hyper-
polarising shift in the voltage at half-maximal activation. In
addition, N-MSTX-Mb1a failed to a¡ect TTX-resistant sodium
currents. Subsequent Edman degradation revealed a 42-residue
peptide with unusual N- and C-terminal cysteines and a cysteine
triplet (Cys1416). This toxin was highly homologous to a family
of N-atracotoxins (N-ACTX) from Australian funnel-web spiders
including conservation of all eight cysteine residues. In addition
to actions on sodium channel gating and kinetics to N-ACTX,
N-MSTX-Mb1a caused signi¢cant insect toxicity at doses up to
2000 pmol/g. N-MSTX-Mb1a therefore provides evidence of a
highly conserved spider N-toxin from a phylogenetically distinct
spider family that has not undergone signi¢cant modi¢cation.
/ 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Australian mouse spiders (Araneae, Mygalomorphae, Acti-
nopodidae) are one of the oldest groups of spiders in the
Australo-Papuan region. Importantly, the male eastern mouse
spider (Missulena bradleyi), restricted to the east coast of
mainland Australia, can cause systemic envenomation in hu-
mans. The symptoms of envenomation, including muscle fas-
ciculation, tachycardia, dyspnoea, and profuse sweating, are
remarkably similar to those reported for Australian funnel-
web spiders (Aranaea, Mygalomorphae, Hexathelidae, Atra-
cinae). The only reported case of severe envenomation in-
volved a 19-month-old girl who lost consciousness within 30
min of being bitten on the ¢nger by a male M. bradleyi. The
administration of Sydney funnel-web spider antivenom, raised
against Atrax robustus venom, surprisingly produced a dra-
matic improvement in her condition and a full recovery was
made following a second dose of antivenom [1]. This
prompted a recent study to characterise the pharmacological
actions of mouse spider venom. Whole male M. bradleyi ven-
om caused rapid muscle fasciculation, a large contracture and
a rapid decrease in indirectly evoked twitches in the chick
biventer cervicis muscle, with activity blocked by A. robustus
antivenom [2]. These actions were found to be due to a re-
duction in the rate of tetrodotoxin (TTX)-sensitive sodium
current inactivation and a hyperpolarising shift in the thresh-
old of activation of TTX-sensitive sodium currents [2]. The
modulation of sodium channel gating and kinetics, and rever-
sal by A. robustus antivenom, indicate that the venom from
male M. bradleyi may contain vertebrate-active neurotoxins
that have a similar action to those found in Australian fun-
nel-web spider venoms, despite the fact that mouse spiders are
taxonomically distinct from funnel-web spiders.
Previous studies on the venom of Australian funnel-web
spiders have revealed a number of toxins, called atracotoxins
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N-ACTX-Ar1a, N-atracotoxin-Ar1a (formerly robustoxin) from the
Sydney funnel-web spider Atrax robustus ; N-ACTX-Hv1a, N-atraco-
toxin-Hv1a (formerly versutoxin) from the Blue Mountains funnel-
web spider Hadronyche versuta ; N-ACTX-Hv1b, N-atracotoxin-Hv1b
from Hadronyche versuta ; N-ACTX-Hs20.1a, N-atracotoxin-Hs20.1a
from Hadronyche sp. 20; Lqh II, anti-mammal K-toxin from the scor-
pion Leiurus quinquestriatus hebraeus ; Aah-II, anti-mammal K-toxin
from the scorpion Androctonus australis hector ; LqhKIT, K-insect tox-
in from the scorpion Leiurus quinquestriatus hebraeus ; SDS^PAGE,
sodium dodecyl sulphate^polyacrylamide gel electrophoresis; PVDF,
polyvinylidene £uoride; TBS, Tris-bu¡ered saline; FWS-AV, Sydney
funnel-web spider antivenom; RP-HPLC, reverse-phase high-perfor-
mance liquid chromatography; TFA, tri£uoroacetic acid; DRG, dor-
sal root ganglion; HEPES, N-2-hydroxyethylpiperazine-N-2-ethane-
sulfonic acid; TEA, tetraethylammonium; (+)-TC, (+)-tubocurarine;
LD50, median lethal dose; PD50, median paralytic dose; ApB, antho-
pleurin-B from the sea anemone Anthopleura xanthogrammica ; Magi
4, sodium channel toxin from the spider Macrothele gigas
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(ACTX), that are responsible for the neurotoxic action seen
with whole venom (for a review see [3]). However, the lethal
toxins responsible for the major primate-speci¢c symptoms of
envenomation are the N-ACTX shown to target the voltage-
gated sodium channel (for a review see [4]). To date, four N-
ACTX have been identi¢ed, these include N-ACTX-Ar1a from
the Sydney funnel-web spider (A. robustus) [5], N-ACTX-Hv1a
[6] and -Hv1b [7] from the Blue Mountains funnel-web spider
(Hadronyche versuta) and N-ACTX-Hs20.1a from Hadronyche
sp. 20 [4]. All N-ACTX are highly homologous 42-residue pep-
tides with a high proportion of basic residues and are cross-
linked by four conserved intramolecular disul¢de bonds.
These peptide, like many spider neurotoxins, also contain an
‘inhibitor cystine-knot’ motif [8^10]. N-ACTX produce a slow-
ing of TTX-sensitive sodium current inactivation, a modest
hyperpolarising shift in the voltage dependence of activation
and a reduction in peak sodium current [4,7,11,12]. This re-
sults in spontaneous repetitive ¢ring accompanied by plateau
potentials [13,14]. Of great interest has been the ¢nding that
N-ACTX, in addition to being mammalian toxic, are also in-
secticidal. Both N-ACTX-Ar1a and -Hv1a are toxic by later-
oventral injection into crickets [15] and target the insect vol-
tage-gated sodium channel to cause similar actions on
neuronal excitability as seen in vertebrate preparations [13].
Notably, these actions on insect and mammalian voltage-
gated sodium channels are similar, but not identical, to the
mechanism of action of scorpion K-toxins and sea anemone
toxins [16,17].
Neurochemical studies have shown that at nanomolar con-
centrations N-ACTX compete with both anti-mammalian (e.g.
Lqh-II and Aah-II) and anti-insect (e.g. LqhKIT) scorpion
K-toxins for neurotoxin receptor site-3 on voltage-gated so-
dium channels [15,18,19] (for a review of sodium channel neu-
rotoxin receptor sites, see Gordon [20]). Therefore, it is clear
that the N-ACTX are extremely potent and de¢ne a new class
of toxins a¡ecting both insect and mammalian voltage-gated
sodium channels.
Interestingly, the three-dimensional fold of N-ACTX is dif-
ferent from the previously determined structures of all other
site-3 neurotoxins despite similar actions on sodium current
inactivation [8]. At present, the toxin pharmacophore of
N-ACTX is unknown but is believed to involve a number of
basic residues distributed in a topologically similar manner to
basic residues in scorpion K-toxins and sea anemone toxins
despite distinctly di¡erent protein sca¡olds [8]. This is sup-
ported by the ¢nding that N-ACTX-Hv1b, a neurotoxin that
is devoid of insecticidal activity and has reduced mammalian
activity, lacks several N-terminal basic residues [7].
The present investigation describes the biochemical and
pharmacological characterisation of a novel neurotoxin,
N-missulenatoxin-Mb1a (N-MSTX-Mb1a), from the phyloge-
netically distinct spider family Actinopodidae. This spider
neurotoxin has a similar mode of action and primary structure
to the N-ACTX and provides further evidence for the key role
of N-terminal basic residues in the action of N-ACTX.
2. Materials and methods
2.1. Venom electrophoresis and Western blotting
Crude venom from male and female eastern mouse spiders
(M. bradleyi) was collected as previously described [2]. Sodium dodec-
yl sulphate^polyacrylamide gel electrophoresis (SDS^PAGE) of
M. bradleyi venom was performed under reducing conditions accord-
ing to the method of Laemmli [21] using 10^20% Tris^tricine gradient
gels (Novex, San Diego, CA, USA). The molecular weight marker
lane consisted of markers of 3.4^26.6 kDa (Life Science Research
Products, Regents Park, NSW, Australia). Following electrophoresis,
protein bands were stained using silver nitrate.
Western blotting was performed following initial SDS^PAGE elec-
trophoresis as described above. Proteins were transblotted onto poly-
vinylidene £uoride (PVDF) membrane (Bio-Rad Laboratories, Her-
cules, CA, USA) in Tris^tricine^methanol transfer bu¡er using 200
mA constant current for 1 h. The PVDF membrane was incubated
with 3% w/v bovine serum albumin (BSA) in phosphate-bu¡ered sa-
line for 1 h at room temperature. It was then washed in Tris-bu¡ered
saline (pH 8.0)^Tween 0.05% v/v (TBS^Tween), followed by incuba-
tion with funnel-web spider antivenom raised against male Sydney
funnel-web spider (A. robustus) venom (FWS-AV) (Commonwealth
Serum Laboratories, Melbourne) at a dilution of 1:500 for 1 h. The
washing step was repeated and the blot was then incubated with a
1:5000 dilution of the secondary antibody, alkaline phosphatase con-
jugated goat-anti-rabbit IgG (Sigma Laboratories, St Louis, MO,
USA), for 1 h. It was then washed again with TBS^Tween and devel-
oped with 5-bromo-4-chloro-indoyl phosphate p-toluidine plus nitro-
blue tetrazolium.
2.2. Toxin puri¢cation and sequencing
Pooled venom was initially fractionated using reverse-phase high-
performance liquid chromatography (RP-HPLC) employing a Vydac
analytical column (C18, 4.6U250 mm, 5 Wm) on a Shimadzu HPLC
system. Peptide peaks were monitored at an absorbance of 215 nm.
Elution of venom peptide components was achieved using a linear
gradient of 5^60% v/v acetonitrile/0.1% v/v tri£uoroacetic acid
(TFA) over 55 min at a £ow rate of 1 ml/min. Selected fractions
were subjected to vertebrate toxicity bioassays using a chick biventer
cervicis nerve-muscle preparation to determine vertebrate toxicity (see
Section 2.3). The major toxic fraction, N-MSTX-Mb1a (peak a in Fig.
1C), eluted around 33% acetonitrile concentration and was further
puri¢ed on an analytical C18 RP-HPLC column using a linear gra-
dient of 5^32% acetonitrile/0.1% TFA over 5 min, then 32^34% ace-
tonitrile/0.1% TFA over 20 min, at a £ow rate of 1 ml/min. Puri¢ed
toxin was collected, lyophilised and stored at 320‡C until required.
Toxin quanti¢cation was performed using a BCA (bicinchoninic acid)
Protein Assay Kit (Pierce, Rockford, IL, USA) using BSA as a stan-
dard. Absorbances were read at 560 nm on a Titertek Multiscan
microplate reader (E£ab, Finland). The molecular mass was deter-
mined by electrospray ionisation mass spectrometry. In preparation
for amino acid sequencing, the toxin was reduced and cysteine resi-
dues were pyridylethylated as described previously [8]. The reduced,
pyridylethylated toxin was puri¢ed using RP-HPLC as described pre-
viously [8], then the entire peptide sequence was obtained from a
single sequencing run on an Applied Biosystems/Perkin Elmer Procise
492 cLC protein sequencer.
2.3. Chick isolated biventer cervicis nerve-muscle bioassay
Vertebrate toxicity was con¢rmed by the use of an isolated chick
biventer cervicis nerve-muscle preparation as described previously
[22,23]. Brie£y, biventer cervicis muscles with attached nerve were
removed from male Australorp chicks (1^4-day-old), mounted in 8-
ml organ baths and bathed in Krebs^Henseleit solution containing (in
mM): NaCl 118.4, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2,
NaHCO3 25.0, D-glucose 11.1, pH 7.4. The muscle was maintained
at 34‡C and constantly carbogenated with 95% O2 and 5% CO2.
Twitch contractions were elicited by indirect supramaximal stimula-
tion of the motor nerve (supramaximal voltage, 0.05 ms, 0.1 Hz) via
ring electrodes connected to a Grass S88 stimulator. Isometric con-
tractions of the muscle were recorded using a Neomedix isometric
force transducer, connected to a T-218 ampli¢er and a MacLab/4s
data acquisition system (AD Instruments, Castle Hill, NSW, Austra-
lia) connected to a Centris 650 Macintosh computer. In the absence of
electrical stimulation, responses to exogenous acetylcholine (1 mM, 30
s) and KCl (40 mM, 30 s) were obtained prior to the addition of
venom and at the conclusion of the experiment. Preparations were
allowed to equilibrate for at least 30 min with continuous stimulation
before the addition of venom or antivenom. All animal experimenta-
tion was approved by the joint Animal Care and Ethics Committee of
the University of Technology, Sydney, and the Royal North Shore
Hospital, Sydney, Australia.
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2.4. Electrophysiological studies
Acutely dissociated dorsal root ganglion (DRG) neurones were pre-
pared from 4^12-day-old Wistar rats and maintained in short-term
primary culture using the method described by Nicholson et al. [11].
Voltage-clamp recordings were made with the whole-cell patch-clamp
technique [24] using an AxoPatch 200A patch-clamp ampli¢er (Axon
Instruments, Foster City, CA, USA). Micropipettes were pulled from
borosilicate glass capillary tubing (Corning 7052 Glass, Warner In-
struments) and had d.c. resistances of 0.8^2.0 M6.
To record macroscopic sodium currents, micropipettes were ¢lled
with a solution of the following composition (in mM): CsF 135; NaCl
10; N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES) 5;
with the pH adjusted to 7.0 with 1 M CsOH. The external bathing
solution contained (in mM): NaCl 30; MgCl2 1; CaCl2 1.8; CsCl 5;
KCl 5; D-glucose 25; HEPES 5; tetraethylammonium (TEA)^Cl 20;
tetramethylammonium chloride 70; with the pH adjusted to 7.4 with
1 M TEA^OH.
The osmolarity of both solutions was adjusted to 290^300 mOsm/l
with sucrose to reduce osmotic stress. The external solution was ap-
plied to the perfusion chamber via a gravity-fed perfusion system and
the £ow rate maintained at 0.5 ml/min using a Gilmont £owmeter
(Barrington, IL, USA). Data were recorded at room temperature
(20^23‡C) which did not £uctuate more than 1‡C during the course
of an experiment. In all voltage-clamp experiments the holding poten-
tial was 380 mV and the sodium concentration of the external solu-
tion was reduced to 30 mM to improve series resistance compensation
and to avoid saturation in the recording system [25]. Inverted voltage-
clamp command pulses were applied to the bath through a Ag/AgCl
pellet/3 M KCl^agar bridge. The liquid junction potential between
internal and external solutions was approximately 36 mV, and all
data were compensated for this value.
Large round DRG cells with diameters of 30^50 Wm were selected
for experiments. Larger cells from older animals tended to express fast
TTX-sensitive sodium currents (INa) whilst smaller cells tended to
express predominately TTX-resistant INa [26]. In those experiments
that assessed the actions of the toxin on TTX-resistant INa, 200 nM
TTX was applied to the external solution to eliminate any residual
TTX-sensitive INa. Only those cells that exhibited less than 10% TTX-
resistant INa, as determined from di¡erences in the steady-state so-
dium channel inactivation pro¢le, were used to determine the actions
of toxin on TTX-sensitive INa. After breaking through the membrane,
experiments did not commence for a period of 15^20 min to allow for
the complete block of calcium and potassium currents and any fast
time-dependent shifts in steady-state inactivation. The experiments
used in this study were rejected if there were large leak currents or
currents showed signs of poor space clamping such as an abrupt
activation of currents upon relatively small depolarising pulses.
Stimulation and recording were both controlled by an AxoData0
data acquisition system (Axon Instruments) running on an Apple
Macintosh Quadra 700. Data was ¢ltered at 5 kHz (four-pole low-
pass Bessel ¢lter) and digital sampling rates were between 15 and 25
kHz depending on voltage protocol length. Leakage and capacitive
currents were digitally subtracted with P-P/4 procedures [27] and se-
ries resistance compensation was set at s 80% for all cells. Data
analysis was performed o¡-line following completion of the experi-
ment. Mathematical curve ¢tting employed algorithms available in
KaleidaGraph0 for Macintosh using a non-linear least-squares meth-
od. The curve ¢ts for the I/V data were obtained using the following
equation:
INa ¼ gmax 13 11þ exp½ðV3V 1=2Þ=s
  
ðV3V revÞ ð1Þ
where INa is the amplitude of the peak sodium current at a given
potential, V, gmax is the maximal sodium conductance, V1=2 is the
voltage at half-maximal activation, s is the slope factor and Vrev is
the reversal potential.
2.5. Invertebrate toxicity assays
Insect toxicity was determined by lateroventral thoracic injection of
the puri¢ed toxin into 3rd^4th instar house crickets nymphs (Acheta
domesticus, sex undetermined) as described previously [28] at doses up
to 2000 pmol/g. Crickets received injections of toxin dissolved in in-
sect saline of the following composition (in mM): NaCl 200, KCl 3.1,
CaCl2 5, MgCl2 4, HEPES 10, sucrose 50, pH 7.4. Insects were moni-
tored for 72 h postinjection for signs of paralysis or lethality.
2.6. Statistics
Comparisons of two sample means were made using a Wilcoxon
signed-rank test or paired Student’s t-test (as speci¢ed). A test was
considered to be signi¢cant when P6 0.05. Data, when quanti¢ed,
were expressed as meansUS.E.M.
3. Results
3.1. Venom electrophoresis and Western blotting
SDS^PAGE revealed considerable variability in the number
of protein bands between pooled male and female M. bradleyi
venom. In particular, constant bands were only present
around 7 kDa and 90 Da. In addition, separation patterns
of both male and female venom was less complex than fun-
nel-web spider venoms [29]. Notably, male venom appears to
have a band around 4900 Da that is absent from female
venom (see band marked with * in Fig. 1A). It has been
previously reported that female M. bradleyi venom does not
produce neurotoxicity in vertebrate nerve-muscle preparations
[2] and that male venom appears to contain a vertebrate-ac-
tive neurotoxin with similar actions as N-ACTX that have a
molecular weight of V4900 Da.
Given that FWS-AV reverses the e¡ects of male M. bradleyi
envenomation, we assessed if FWS-AV would bind to protein
fractions in either male or female venom. Western blotting
revealed that FWS-AV bound to protein fractions above a
molecular weight of 14 kDa. There was little antivenom bind-
ing to protein fractions between 5 and 14 kDa. Importantly,
only male venom showed bands less than 5 kDa consistent
with the presence of a possible N-ACTX-like neurotoxin (see
band marked with * in Fig. 1B).
3.2. Toxin puri¢cation
A vertebrate-active neurotoxin in male M. bradleyi venom
was puri¢ed by RP-HPLC. Fig. 1C shows a RP-HPLC chro-
matogram of pooled venom. The fraction containing the toxin
eluted at 33% acetonitrile/0.1% TFA (peak a, Fig. 1C). This
peak was found to cause strong muscle contracture, fascicu-
lation and to decrease nerve-evoked twitch contractions of
chick isolated biventer cervicis muscle (data not shown) sim-
ilar to those elicited by N-ACTX-Hv1a and other Australian
funnel-web spider venoms [29]. This fraction was pooled and
lyophilised, and further puri¢cation, using C18 RP-HPLC
with a shallow acetonitrile gradient, yielded three distinct
components (Fig. 1D). The major peak, labelled peak b in
Fig. 1D, was subsequently shown to be the most active com-
ponent in the chick biventer cervicis nerve-muscle assay.
MALDI-TOF (matrix-assisted laser desorption/ionisation
time-of-£ight) mass spectrometry revealed that the molecular
mass of the peptide peak b was 4933U 1 Da.
3.3. Determination of amino acid sequence
Peak b was reduced and the cysteines pyridylethylated in
preparation for N-terminal amino acid sequencing to assist in
determining the number of cysteine residues. In addition,
phenylthiohydantoin-Cys with a pyridylethylated sidechain is
stable during automated N-terminal amino acid sequencing
and therefore allows positive identi¢cation of Cys residues.
Mass spectral analysis of the pyridylethylated toxin indi-
cated that it contained eight cysteine residues. The amino
acid sequence of the toxin (see Fig. 2), obtained in a single
sequencing run without the need to resort to proteolytic di-
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gestion, revealed that it contains 42 residues, including eight
cysteines. Importantly, it possesses both N- and C-terminal
cysteines and an unusual cysteine triplet (Cys1416). The pre-
dicted mass of 4934 Da for the fully oxidised peptide, in which
the eight cysteine residues form four disulphide bonds, is con-
sistent with the mass spectral analysis.
The toxin displayed signi¢cant homology with three
other Australian funnel-web spider toxins, N-ACTX-Hv1a [2]
and N-ACTX-Hv1b [7] isolated from the venom of the female
Blue Mountains funnel-web spider, H. versuta, and N-ACTX-
Ar1a [21] isolated from the venom of the male Sydney funnel-
web spider, A. robustus. The sequence shows conservation in
the number and spacing of cysteine residues. When conserva-
tive substitutions are taken into consideration, the homology
Fig. 2. Comparison of the amino acid sequences of N-MSTX-Mb1a with currently known members of the N-ACTX family and Magi 4. Identi-
cal residues are shaded black and conservatively substituted residues, relative to N-MSTX-Mb1a, are shaded grey. Toxins are ordered by homol-
ogy to N-MSTX-Mb1a. Gaps (dashes) have been inserted to maximise alignment. The disulphide bonding pattern for the strictly conserved cys-
teine residues determined for N-ACTX-Ar1a [9] and N-ACTx-Hv1a [8] is indicated below the sequences; it is assumed that N-MSTX-Mb1a,
N-ACTX-Hs20.1a [4], N-ACTX-Hv1b [7] and Magi 4 [30] have the same disulphide bonding pattern. Suspected key residues critical for function
[4] are indicated by the arrows. Secondary structure for N-ACTX-Hv1a is shown at the top of the ¢gure where shaded rectangles represent
L-turns (the type of turn is indicated in the rectangle), black arrows represent L-strands, and the black cylinder represents a 310 K-helix [8]. The
percentage identity and homology with N-MSTX-Mb1a is also shown to the right of the sequences.
Fig. 1. A,B: SDS^PAGE gel and Western blot of M. bradleyi venom. A: Silver-stained SDS^PAGE gel showing protein components of male
and female M. bradleyi venom. Left-hand lanes shows high (High MW) and low (Low MW) molecular weight markers. Note a band consistent
with N-MSTX-Mb1a at 4933 Da in whole male venom that is absent in whole female venom. B: Western blot analysis of male and female
M. bradleyi venom using Sydney funnel-web spider antivenom. The left-hand lane (MW) contains molecular weight markers. Note a positive re-
action consistent with N-MSTX-Mb1a in whole male venom that is absent in whole female venom. C,D: RP-HPLC chromatogram of pooled
male M. bradleyi venom. C: Screening of venom fractions revealed that peak a caused spontaneous contractions of chick isolated biventer cer-
vicis nerve-muscle preparations. D: Further RP-HPLC puri¢cation of this fraction yielded three major peaks, the largest of which (peak b) was
found to be the most active component in the chick isolated biventer cervicis nerve-muscle preparation.
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with other N-ACTX ranges from 76 to 95%. The toxin has
nine amino acid substitutions relative to N-ACTX-Hv1a, its
closest ortholog (see Fig. 2). In addition, the toxin shows 64%
sequence homology to the recently identi¢ed sodium channel
toxin Magi 4 from the hexathelid spider Macrothele gigas [30].
Based on the sequence homology and functional similarities
(see below) with N-ACTX, we have named the toxin N-MSTX-
Mb1a in accordance with the nomenclature previously de-
scribed for toxins isolated from Australian funnel-web spiders
[5]. The sequence of N-MSTX-Mb1a has been deposited in the
SwissProt Databank under the accession number P83608.
Although the pairing of cysteines was not determined ex-
perimentally, the high homology in primary structure with
previously described spider N-toxins strongly suggests that
N-MSTX-Mb1a conforms to an inhibitor cystine-knot motif
(Cys1-Cys4, Cys2-Cys6, Cys3-Cys7, Cys5-Cys8)[10,31] as has
been observed for most spider neurotoxins.
3.4. E¡ects of N-MSTX-Mb1a on the isolated chick biventer
cervicis nerve-muscle preparation
In the indirectly stimulated chick biventer cervicis muscle,
N-MSTX-Mb1a (85 nM) caused a rapid muscle contracture
(increase in resting tension), associated with muscle fascicula-
tion and a decrease in twitch tension (Fig. 3A). However,
N-MSTX-Mb1a had no signi¢cant e¡ect on responses to ace-
tylcholine (1 mM: 2.4U 1.4 g before toxin, 2.38U 1.4 g after
toxin), carbachol (20 WM: 1.52U 0.8 g before toxin, 1.45U 0.8
g after toxin) or KCl (40 mM: 2.78U 1.6 g before toxin,
2.23U 1.3 g after toxin) (n=3, Ps 0.05, Wilcoxon signed-
rank test) (data not shown). The contracture induced by
N-MSTX-Mb1a (85 nM) was completely abolished by the
skeletal muscle nicotinic receptor antagonist (+)-tubocurarine
[(+)-TC; 10 WM] and by the sodium channel blocker TTX
(200 nM) (Fig. 3B,C).
A 10-min pretreatment of the indirectly stimulated chick
biventer cervicis muscle with 0.6 U/ml Sydney funnel-web spi-
der antivenom completely prevented the contracture, fascicu-
lations and the attenuation of twitches caused by N-MSTX-
Mb1a (85 nM) (n=3, Fig. 4A). It was also found that the
e¡ects of N-MSTX-Mb1a on the nerve-muscle preparation
could be reversed by subsequent addition of Sydney funnel-
web spider antivenom (0.6 U/ml) (n=3, Fig. 4B).
3.5. E¡ects of N-MSTX-Mb1a on voltage-gated sodium
currents
Under voltage-clamp conditions, N-ACTX have been previ-
ously shown to cause a concentration-dependent reduction in
peak TTX-sensitive INa amplitude and slowing of INa inacti-
vation [4,7,11,12]. Fig. 5A shows the e¡ect of N-MSTX-Mb1a
on TTX-sensitive INa. At 30 nM, N-MSTX-Mb1a reduced
peak TTX-sensitive INa amplitude by 24U 8% (n=3,
P6 0.05, paired Student’s t-test) and slowed the rate of
TTX-sensitive INa inactivation. Analysis of the toxin e¡ect
on inactivation was estimated by measuring the INa remaining
after 50 ms following a step depolarisation to indicate the
proportion of channels with permanently modi¢ed inactiva-
tion. At 310 mV the remaining current was 19.2U 4.2%
(n=3) of control peak INa. Since the reduction in peak INa
at 30 nM was found to be similar for N-MSTX-Mb1a and
both N-ACTX-Hv1a and -Ar1a [11], we conclude that
N-MSTX-Mb1a is approximately equipotent with N-ACTX-
Hv1a and -Ar1a on TTX-sensitive sodium channels. Similar
to N-ACTX, the reduction in sodium current amplitude and
slowing of current inactivation produced by N-MSTX-Mb1a
was only partially reversible after prolonged washing with
toxin-free solution. In marked contrast to its action on
TTX-sensitive sodium channels, N-MSTX-Mb1a (300 nM),
like other N-ACTX [11,12], failed to signi¢cantly alter either
the amplitude or time course of TTX-resistant INa (Fig. 5E).
Previous studies have shown that N-ACTX shift the thresh-
old of activation of TTX-sensitive INa in the hyperpolarising
direction [4,7,11,12]. Analysis of the I/V relationship of TTX-
sensitive INa in the presence of 30 nM N-MSTX-Mb1a (Fig.
5B^D) revealed a similar 10-mV hyperpolarising shift in the
threshold of sodium channel activation. Data were normalised
Fig. 4. Typical traces showing neutralisation of the e¡ects of
N-MSTX-Mb1a by Sydney funnel-web spider antivenom on the indi-
rectly stimulated chick biventer cervicis nerve-muscle preparation.
A: Funnel-web spider antivenom (FWS-AV, 0.6 U/ml) was applied
to the preparation 10 min prior to the application of N-MSTX-
Mb1a (85 nM). Note lack of toxin response. B: FWS-AV (0.6
U/ml) was applied following the application of N-MSTX-Mb1a (85
nM). Note the rapid return of muscle tension to control levels and
reversal of muscle fasciculation.
Fig. 3. Typical e¡ects of antagonists on responses to N-MSTX-
Mb1a in the isolated chick biventer cervicis nerve-muscle prepara-
tion. A: Development of muscle fasciculation and contracture fol-
lowing addition of 85 nM N-MSTX-Mb1a. The dotted line indicates
the resting tension of the muscle. B,C: Following exposure to 10
WM (+)-TC (B) or 200 nM TTX (C) 85 nM N-MSTX-Mb1a fails to
alter twitch or resting muscle tension.
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Fig. 5. Typical e¡ects of N-MSTX-Mb1a on TTX-sensitive and TTX-resistant INa in rat DRG neurones. Panels show the e¡ect of N-MSTX-
Mb1a on TTX-sensitive (left hand) and TTX-resistant (right hand) INa. A,E: Superimposed current traces recorded following a 50-ms depolar-
isation to 310 mV from a holding potential of 390 mV, before, and 10 min after, toxin application. A: Note the reduction in peak current
amplitude of TTX-sensitive INa and slowed inactivation kinetics. E: Lack of e¡ect of 300 nM N-MSTX-Mb1a on TTX-resistant INa elicited by
the same stimulus protocol. Both current responses were recorded in the presence of 200 nM TTX to eliminate residual TTX-sensitive INa. Re-
maining panels show typical e¡ects of N-MSTX-Mb1a on the current^voltage (I/V) relationship of TTX-sensitive (B^D) and TTX-resistant
(F^H) INa. Families of INa were evoked by a series of 50-ms depolarisations from 390 to +70 mV in 10-mV steps applied every 10 s from a
holding potential of 390 mV. Families of INa before (B,F) and after (C,G) application of 30 nM N-MSTX-Mb1a. For clarity, INa recorded in
20-mV steps are presented. Note that the inactivation kinetics of both inward and outward currents are slowed and incomplete in panel C
only. D,H: Peak (circles) and late (triangles) I/V relationships are shown before (empty symbols) and following (¢lled symbols) a 10-min perfu-
sion with 30 nM N-MSTX-Mb1a. Late currents were measured at the end of each 50-ms depolarising test pulse. Peak and late currents were ¢t-
ted according to Eq. 1 described in Section 2. Note that no shift in the threshold of activation is seen in panel H.
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and ¢tted using a single Boltzmann distribution. N-MSTX-
Mb1a caused a hyperpolarising shift in the voltage at half-
maximal activation (V1=2) from 322.6U 1.4 mV (n=3,
P6 0.05, paired Student’s t-test) in controls to 333.2U 0.4
mV with no change in the slope factor s. Fig. 5 also shows
that these changes occurred in the absence of signi¢cant
changes in the reversal potential which were only slightly de-
creased from 29.8 mV (calculated from the Nernst equation)
by 1.2 U 0.5 mV (Ps 0.05, paired Student’s t-test). These
changes could not be explained by spontaneous time-depen-
dent shifts in the voltage dependence of activation, which in
general are 6 5 mV in DRG neurones (G. Nicholson, unpub-
lished results).
Consistent with N-ACTX, and in marked contrast to its
action on TTX-sensitive INa, N-MSTX-Mb1a (300 nM) failed
to signi¢cantly alter the voltage dependence of activation of
TTX-resistant INa (see Fig. 5F^H).
3.6. Insecticidal activity of N-MSTX-Mb1a
N-ACTX-Hv1a was previously shown to be a moderately
potent insecticidal toxin, with a median lethal dose (LD50)
of 770 pmol/g in house crickets (A. domesticus) [15] Further-
more, N-ACTX-Hv1a caused contractile paralysis at signi¢-
cantly lower doses [median paralytic dose (PD50) = 200
pmol/g], with the higher LD50 re£ecting the fact that most
crickets recover from the contractile paralysis at doses near
or below the PD50 [15]. However N-ACTX-Hv1b showed a
complete absence of insect toxicity at doses up to 2000
pmol/g. Crickets were injected with N-MSTX-Mb1a at doses
up to 2000 pmol/g and within 20 min of injection showed
signs of neurotoxicity including continuous and involuntary
spasms of the appendages, abdomen and head. There was a
moderate loss of co-ordination when walking, and some crick-
ets showed marked latero£exion of their abdomen. Interest-
ingly, there was some reversal of these signs of toxicity, with
the exception of abdominal latero£exion, within 24 h post-
injection and at doses below 1000 pmol/g insects recovered
completely. Nevertheless, lethality was observed in 60% of
crickets at a dose of 2000 pmol/g after 48 h, indicating that
N-MSTX-Mb1a is approximately two-fold less toxic to crick-
ets than N-ACTX-Hv1a.
4. Discussion
This paper describes the isolation and characterisation of a
peptide neurotoxin that modulates vertebrate sodium channel
inactivation from a spider species unrelated to Australian
funnel-web spiders (Hexathelidae). N-terminal sequencing
showed that the actinopodid toxin N-MSTX-Mb1a corre-
sponds to a 42-residue peptide of molecular weight 4933 Da
that is clearly a close ortholog of N-ACTX-Hv1a and related
hexathelid spider N-toxins. The cysteine spacing with char-
acteristic N- and C-terminal cysteines and cysteine triplet,
characteristic of spider N-toxins, strongly suggests that this
novel toxin belongs to the inhibitor cystine-knot motif group
of peptides. N-MSTX-Mb1a mimics the neurotoxicity of
N-ACTX-Hv1a [29], causing a sustained contracture and
muscle fasciculation of vertebrate skeletal muscle, consistent
with similar signs of envenomation in vivo. This appears to be
the result of spontaneous neurotransmitter release from motor
nerve terminals and not an alteration in postjunctional exci-
tation^contraction coupling. This was evident from the fact
that responses of slow muscle ¢bres to KCl and acetylcholine
in the chick nerve-muscle preparation were una¡ected and the
contracture was blocked by prior application of TTX or (+)-
TC. These presynaptic actions to induce neurotransmitter re-
lease, particularly in cholinergic nerve ¢bres, are consistent
with those reported in clinical cases of severe envenomation
or in vitro studies with whole venom [1,2]. In addition, the
actions of the toxin could be neutralised or reversed by Syd-
ney funnel-web spider antivenom consistent with previous in
vitro and in vivo studies [2]. The present ¢ndings provide
additional evidence for the cross-reactivity of Sydney funnel-
web spider antivenom and supports the potential e¡ectiveness
of this antivenom in cases of systemic envenomation by male
M. bradleyi.
Given that previously characterised spider N-toxins are, by
de¢nition, potent modulators of sodium channel inactivation
[14,15], we investigated whether N-MSTX-Mb1a modulated
sodium channel gating or kinetics. The ¢ndings of this study
demonstrate that N-MSTX-Mb1a has selective e¡ects on
TTX-sensitive INa including: (a) a slowing of channel inacti-
vation, (b) a reduction in peak current amplitude, and (c) shifts
in the voltage dependence of activation. In contrast, and con-
sistent with spider N-toxins, TTX-resistant sodium channel
gating and kinetics remained una¡ected.
These actions, especially the slowing of INa inactivation in
the absence of large shifts in the voltage dependence of acti-
vation or profound slowing of deactivation, indicates that
N-MSTX-Mb1a acts in a manner similar to scorpion K-toxins,
sea anemone toxins, and previously characterised N-ACTX
that bind to neurotoxin receptor site-3. The above actions
of N-MSTX-Mb1a indicate that it inhibits conversion of the
voltage-gated sodium channel from the open to the inacti-
vated state, resulting in sodium currents remaining at mem-
brane potentials where inactivation is normally complete. This
is qualitatively similar to all other N-ACTX, apart from the
vertebrate-selective N-ACTX-Hv1b that appears to be approx-
imately 15- to 30-fold less potent in its modulation of verte-
brate sodium channel gating and kinetics. In addition,
N-MSTX-Mb1a like other spider N-toxins, except N-ACTX-
Hv1b, possesses both insect and vertebrate toxicity, albeit
with slightly reduced insecticidal potency. This is presumably
due to binding to insect voltage-gated sodium channels at site-
3 to slow inactivation as has been previously observed with
N-ACTX-Hv1a [13,15,32].
Given the high similarity in the primary sequence, cysteine
spacing and bioactivity, as well as a common antibody epi-
tope, it seems plausible that N-MSTX-Mb1a shares a similar
inhibitor cystine-knot motif, 3D structure and importantly a
similar pharmacophore to that of N-ACTX. Unfortunately,
work to identify the bioactive surface of N-ACTX has been
hampered by the four disul¢de bonds preventing the refolding
of synthetic or recombinant toxin in su⁄cient yields to at-
tempt mutagenesis studies. Nevertheless, critical residues in-
volved in N-ACTX binding have been delineated by matching
topologically related residues on the bioactive surface of
LqhKIT, a scorpion K-toxin. Previous mutagenesis studies
have shown that several basic, non-polar and aromatic resi-
dues that constitute the bioactive surface of LqhKIT [33] clus-
ter in a similar fashion on the counterpart surface of the site-3
toxins Aah-II and ApB and, interestingly, also appear on the
surface of both N-ACTX-Hv1a and -Ar1a, despite distinctly
di¡erent protein sca¡olds [32]. In the spider N-toxins, that are
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toxic to both insects and vertebrates, these are the positively
charged residues Lys3, Lys4, Arg5 and Lys10, the non-polar
Asn6 and the aromatic residues Trp7 and Tyr22/Tyr25 [32]
(for a review see [4]). Importantly all residues apart from
Asn6 are conserved in the ortholog N-MSTX-Mb1a lending
further support to the hypothesis that they form the bioactive
surface of spider N-toxins targeting site-3 of the sodium chan-
nel.
Importantly, close inspection of the primary structure of the
spider N-toxins reveals that a number of amino acids are not
conserved between N-ACTX-Hv1b and other hexathelid spider
N-like toxins including Magi 4 from M. gigas [30] and the
actinopodid spider N-toxin, N-MSTX-Mb1a (see Fig. 2). It is
assumed that Magi 4 is a spider N-toxin since it shows se-
quence homology to N-ACTX, is lethal to mammals and in-
sects, and competes with LqhKIT for site-3 on insect sodium
channels. Interestingly though, it fails to compete with Lqh-II
for binding to rat brain synaptosomes and therefore shows
unusual binding characteristics despite being toxic when in-
jected intracerebroventricularly in mice [30]. Signi¢cantly,
N-ACTX-Hv1b lacks insect toxicity and has a 15- to 30-fold
reduction in vertebrate toxicity, however, it has non-conser-
vative K4S, R5D, and Y22K substitutions in comparison to
spider N-toxins and Magi 4 that are all known to be toxic to
insects and vertebrates. This lends support to the hypothesis
that these basic and aromatic residues are important for full
vertebrate and insect activity.
The similar disposition of these residues on the distinctly
dissimilar 3D surface of site-3 peptide toxins from scorpions,
sea anemones and spiders, demonstrates the putative route of
convergent evolution of receptor site-3 ligands. In addition,
the highly conserved sequence homology between two phylo-
genetically distinct and primitive spider families (Actinopodi-
dae vs. Hexathelidae) provides evidence to suggest that there
is strong selection pressure to maintain such highly toxic pep-
tides despite potential evolutionary mutation. This provides
strong evidence of the highly optimised nature of peptide neu-
rotoxins especially those from spider venoms.
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